The Anti-Atherogenic Potential of Liposome-Mediated Delivery of LXR Agonists to Macrophages: A Preclinical Validation Study
Atherosclerosis Supplements - Ireland
doi 10.1016/j.atherosclerosissup.2018.04.021
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
Elsevier BV